Research programme: autoimmune disease vaccines - Innogenetics
Latest Information Update: 27 Nov 2007
At a glance
- Originator Innogenetics
- Class Vaccines
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 05 Jul 2004 Preclinical trials in Autoimmune disorders in Belgium (unspecified route)